Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 99Terminated 25Active not recruiting 12Recruiting 11Unknown 9Withdrawn 8Not yet recruiting 3Suspended 1

Sponsor Class

OTHER 232INDUSTRY 74OTHER_GOV 8NIH 3NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Non-Muscle Invasive Bladder Neoplasms 3Melanoma 3Leukemia, Myeloid, Acute 3Carcinoma, Non-Small-Cell Lung 3Sarcoma, Kaposi 2Sarcoma, Alveolar Soft Part 2Prostatic Neoplasms 2Lymphoma 2Colorectal Neoplasms 2Clear-cell metastatic renal cell carcinoma 2Carcinoma, Renal Cell 2Breast Neoplasms 2Urinary Incontinence 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Solid Tumor 1Skin Neoplasms 1Sarcoma, Synovial 1Sarcoma, Clear Cell 1Sarcoma 1Rhabdomyosarcoma 1Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Neurofibrosarcoma 1Neoplasms 1Musculoskeletal Pain 1Multiple Myeloma 1Malignant Solid Neoplasm 1

Interventions

sacituzumab govitecan 1Specimen Handling 1Pharmaceutical Preparations 1Magnetic Resonance Spectroscopy 1Lidocaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × NETWORK × Carcinoma, Non-Small-Cell Lung × Clear all
NCT07393555 2026-02-06

Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)

SWOG Cancer Research Network

Phase 2 Not yet recruiting
117 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07347977 2026-01-16

LidCRM

First Affiliated Hospital of Ningbo University

Phase NA Not yet recruiting
1,400 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT07234877 2025-11-19

A Randomized Phase II Study Evaluating Upfront SRT to All Brain Metastases Followed by Ivonescimab Plus Chemotherapy Versus Upfront Ivonescimab Plus Chemotherapy in Patients With Asymptomatic Active Brain Metastases From NSCLC

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Not yet recruiting
158 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡